文献速递生殖医学

真核阴道病毒组与预防性抗生素暴露及接受体外受精的低生育力人群生殖结局的关联:一项前瞻性探索性研究

Association of the eukaryotic vaginal virome with prophylactic antibiotic exposure and reproductive outcomes in a subfertile population undergoing in vitro fertilisation: a prospective exploratory study.
PubMed 文献 · BJOG · 2019-10-20

该前瞻性探索性研究在单一生育中心纳入26名首次接受体外受精(IVF)并新鲜胚胎移植的低生育力女性,比较移植前预防性使用阿奇霉素与未使用者的阴道真核DNA病毒组及临床妊娠率。结果显示阿奇霉素组疱疹病毒和α-乳头瘤病毒多样性更高(P=0.04),接受阿奇霉素者中未获临床妊娠者的病毒多样性高于妊娠者(P=0.06),但各组IVF结局无显著差异,病毒多样性与总体临床妊娠无关联。

要点

  • 阿奇霉素组疱疹病毒和α-乳头瘤病毒多样性高于未使用组(P=0.04)。
  • 接受阿奇霉素者中未获临床妊娠者的病毒多样性高于妊娠者(P=0.06)。
  • 阿奇霉素组与未使用组间IVF结局无显著差异,病毒多样性与总体临床妊娠无关联。

核心结论

  • 接受IVF女性的阴道真核病毒组与抗生素暴露相关。
  • 病毒多样性与妊娠之间存在反向趋势,在阿奇霉素组中检出病毒数越多与未能获得临床妊娠相关。

研究设计与样本

  • 前瞻性探索性研究,在单一生育中心开展。
  • 纳入年龄18至43岁、首次接受IVF并新鲜胚胎移植的低生育力女性。
  • 主要暴露为IVF前预防性使用阿奇霉素或不使用阿奇霉素。
  • 在胚胎移植时采集阴道中段拭子进行病毒组分析。
  • 26名女性在胚胎移植前提供了阴道拭子。

主要发现

  • 阿奇霉素组与未使用阿奇霉素组之间IVF结局无显著差异。
  • 病毒多样性与总体临床妊娠之间无关联。
  • 阿奇霉素治疗组样本中疱疹病毒和α-乳头瘤病毒多样性高于未使用阿奇霉素组(P=0.04)。
  • 在接受阿奇霉素的女性中,未获得临床妊娠组的病毒多样性高于获得临床妊娠组(P=0.06)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to use high-throughput sequencing to describe the vaginal eukaryotic DNA virome in patients undergoing in vitro fertilisation (IVF) to examine associations between the vaginal virome, antibiotic exposure and IVF outcomes. DESIGN: Prospective exploratory study. SETTING: Single academic fertility centre. POPULATION: Subfertile women age 18-43 years undergoing their first IVF cycle with a fresh embryo transfer. METHODS: The primary exposure was prophylactic azithromycin or no azithromycin before IVF. A mid-vaginal swab was obtained at the time of embryo transfer for virome analysis. MAIN OUTCOME MEASURES: The primary outcomes compared between exposure groups were characteristics of vaginal virome and clinical pregnancy rates. Secondary outcomes were virome associations with number of oocytes retrieved, number of blastocysts and implantation rate. RESULTS: Twenty-six women contributed a vaginal swab before embryo transfer. There were no significant differences in IVF outcomes between azithromycin groups. There was no association between viral diversity and clinical pregnancy overall. A higher diversity of herpesviruses and α-papillomaviruses was observed in samples from the azithromycin-treated group compared with the no azithromycin group (P = 0.04). In women that received azithromycin, viral diversity was higher in the group that did not achieve clinical pregnancy compared with those who did (P = 0.06). CONCLUSIONS: We demonstrate that the vaginal eukaryotic virome in women undergoing IVF is associated with antibiotic exposure. Additionally, we demonstrate an inverse trend between viral diversity and pregnancy, with a higher number of viruses detected associated with failure to achieve clinical pregnancy in the azithromycin group. TWEETABLE ABSTRACT: Higher viral diversity is associated with prophylactic antibiotic exposure in subfertile women undergoing IVF.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Eskew AM, Stout MJ, Bedrick BS, et al. Association of the eukaryotic vaginal virome with prophylactic antibiotic exposure and reproductive outcomes in a subfertile population undergoing in vitro fertilisation: a prospective exploratory study. BJOG. 2019. PMID: 31529767. doi:10.1111/1471-0528.15951

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。